Posted by Michael Wonder on 04 Apr 2021
Cystic fibrosis medicine applications to be considered by PHARMAC and Medsafe in parallel
1 April 2021 - PHARMAC met this week with Vertex, a supplier of cystic fibrosis medicines, and with Medsafe, the safety and quality regulator for medicines.
The meeting was an opportunity to discuss Vertex’s modulator therapy and the process for this type of treatment to be made available in New Zealand.
